BiotechTube
Home/Pipeline/CA102N

CA102N

Age‑related macular degeneration

PreclinicalActive

Key Facts

Indication
Age‑related macular degeneration
Phase
Preclinical
Status
Active
Company
Holy Stone Healthcare

About Holy Stone Healthcare

Taiwan biotech leveraging hyaluronic‑acid biopolymers for targeted brain, eye, and tumor drug delivery.

View full company profile

Therapeutic Areas

OncologyOphthalmologyNeurology

Other Age‑related macular degeneration Drugs

DrugCompanyPhase
SiRx‑ARMDSiCare BioPreclinical
SB04SynCore BiotechnologyPhase 2/3